Currently, predictions of breast cancer genetic subtypes primarily focus on biomarkers such as estrogen receptor (ER), human epidermal growth factor receptor 2 (HER2), and cell proliferation index (Ki-67) (11–13). Here, ERBB2 is linked to breast carcinoma.